{"title": "Why immunotherapy is not effective for some patients with metastatic melanoma and kidney cancer", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/cancer.xml", "value": "Why immunotherapy is not effective for some patients with metastatic melanoma and kidney cancer"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190325120350.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190325120350.htm", "summary": "White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade (ICB) therapy, according to a new study.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/cancer.xml", "value": "White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade (ICB) therapy, according to a new study."}, "published": "Mon, 25 Mar 2019 12:03:50 EDT", "published_parsed": [2019, 3, 25, 16, 3, 50, 0, 84, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190325120350.htm", "guidislink": false}